One of today's stocks on the move is Isis Pharmaceuticals (NASDAQ:ISIS), up 2.1% to $13.98. The Dow Jones Industrial Average is now trading fractionally lower to 13,504 and the S&P is trading fractionally lower to 1,470.
Isis Pharmaceuticals (NASDAQ:ISIS) is currently priced 23.1% above its average consensus analyst price target of $10.75. The stock should find initial support at its 200-day moving average (MA) of $10.92 and further support at its 50-day MA of $9.68.
In the past 52 weeks, Isis Pharmaceuticals share prices have been bracketed by a low of $6.25 and a high of $15.61 and are now at $13.98, 124% above that low price. The 200-day and 50-day moving averages have moved 0.64% higher and 2.92% higher over the past week, respectively.
Isis Pharmaceuticals, Inc. discovers and develops novel human therapeutic compounds. The company currently has various compounds in clinical trials for a variety of diseases such as Crohn's disease, psoriasis, asthma, and cancer. Isis' broad medical chemistry and biology research programs support efforts in both antisense and small molecule drug delivery.